{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:44:30Z","timestamp":1794674670043,"version":"4.9.1"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","issue":"suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Enferm."],"abstract":"<jats:p>ABSTRACT  Objective: To identify evidence in the literature of the relationship between the use of different hormonal contraceptive methods and alterations in women's blood pressure values.  Method: This is an integrative literature review, consisting of ten scientific articles published in PubMed and BVS, between 2012 and 2016, selected by keywords, available fully and free of charge, in English, Portuguese, or Spanish.  Results: The articles showed that exogenous estrogen helps in the activation of the renin-angiotensin-aldosterone system causing hypertensive effects even in small doses; and that combined use with drospirenone reduces these effects. Routes of administration without passage through the liver and use of isolated progestin showed promising results in reducing the effects on blood pressure.  Conclusion: There is evidence in the literature of pressure alterations associated with different hormonal contraceptives and that personal history of morbidities are to be considered in an attempt to reduce the effects on the cardiovascular system.<\/jats:p>","DOI":"10.1590\/0034-7167-2017-0317","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T20:39:18Z","timestamp":1530995958000},"page":"1453-1459","source":"Crossref","is-referenced-by-count":25,"title":["Effects of different hormonal contraceptives in women's blood pressure values"],"prefix":"10.1590","volume":"71","author":[{"given":"Cristiane Crisp Martins","family":"Ribeiro","sequence":"first","affiliation":[{"name":"Universidade Estadual de Campinas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonieta Keiko Kakuda","family":"Shimo","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena Baena de Moraes","family":"Lopes","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luiz Tatagiba","family":"Lamas","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018]]},"reference":[{"key":"ref1","series-title":"Direitos Humanos. Cerca de 79% das brasileiras usaram m\u00e9todos contraceptivos em 2015, informa ONU","year":"2016"},{"key":"ref2","series-title":"Reproductive Health and Research and John Hopkins Bloomberg School of Public Health. Family planning: a global handbook for providers","year":"2008"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1590\/S0066-782X2011005000022","article-title":"Contracep\u00e7\u00e3o hormonal e sistema cardiovascular","volume":"96","author":"Brito MB","year":"2011","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1590\/S0102-311X1985000200005","article-title":"Anticoncepcionais orais e press\u00e3o arterial: pesquisa epidemiol\u00f3gica de hipertens\u00e3o arterial no Rio Grande do Sul","volume":"1","author":"Szwarcwald C","year":"1985","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin aldosterone system and blood pressure","volume":"61","author":"Oelkers WK","year":"1996","journal-title":"Steroids"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware R","year":"2006","journal-title":"Hum Reprod Update"},{"key":"ref7","first-page":"7","article-title":"Oral contraception: past, present and future perspectives","volume":"37","author":"Mishell Jr DR","year":"1992","journal-title":"Int J Fertil"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren JM","year":"2001","journal-title":"Br Med J"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/ajprenal.00602.2014","article-title":"Transdermal contraception and the renin-angiotensin-aldosterone system in premenopausal women","volume":"308","author":"Odutayo A","year":"2015","journal-title":"Am J Physiol Ren Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.contraception.2013.04.003","article-title":"Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study","volume":"88","author":"Cagnacci A","year":"2013","journal-title":"Contraception"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2012.12.007","article-title":"Effects of progestin-only long-acting contraception on metabolic markers in obese women","volume":"88","author":"Bender NM","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ackd.2014.10.002","article-title":"Our own worst enemy: Pharmacologic mechanisms of hypertension","volume":"22","author":"Kassel LE","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"ref13","first-page":"239","article-title":"Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease","volume":"11","author":"Harvey RE","year":"2015","journal-title":"Womens Health"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6874-13-39","article-title":"Associations between oral contraceptive use and risks of hypertension and prehypertension in a cross-sectional study of Korean women","volume":"13","author":"Park H","year":"2013","journal-title":"BMC Womens Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.contraception.2012.09.017","article-title":"Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review","volume":"87","author":"Steenlanda MW","year":"2013","journal-title":"Contraception"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejogrb.2014.09.006","article-title":"Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age","volume":"182","author":"Morais TL","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jpeds.2014.07.048","article-title":"Initiation of oral contraceptives and changes in blood pressure and body mass index in healthy adolescents","volume":"165","author":"Kharbanda EO","year":"2014","journal-title":"J Pediatr"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1353\/hpu.2013.0172","article-title":"Hypertension among oral contraceptive users in El Paso, Texas","volume":"24","author":"White K","year":"2013","journal-title":"J Health Care Poor Underserved"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12889-015-1392-3","article-title":"Past oral contraceptive use and self-reported high blood pressure in postmenopausal women","volume":"15","author":"Chiu LC","year":"2015","journal-title":"BMC Public Health"},{"issue":"4","key":"ref20","first-page":"392","article-title":"Hipertens\u00e3o arterial e contraceptivos orais","volume":"7","author":"Abrah\u00e3o SB","year":"2000","journal-title":"Rev Bras Hipertens"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/HYPERTENSIONAHA.115.05179","article-title":"Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women","volume":"66","author":"Harvey RE","year":"2015","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0895-7061(95)96212-3","article-title":"Ambulatory blood pressure in mild hypertensive women taking oral contraceptives: a case-control study","volume":"8","author":"Narkiewicz K","year":"1995","journal-title":"Am J Hypertens"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17 beta-estradiol, a novel hormone treatment in postmenopausal woman with stage 1 hypertension","volume":"112","author":"White WB","year":"2005","journal-title":"Circulation"},{"key":"ref24","first-page":"49","article-title":"Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties","volume":"6","author":"R\u00fcbig A","year":"2003","journal-title":"Climateric"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmaccher R","year":"2000","journal-title":"Contraception"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"Van Hylckama Vlieg A","year":"2009","journal-title":"BMJ"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","author":"Lidegaard \u00d8","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.21876\/rcsfmit.v5i2.334","article-title":"Terapia com horm\u00f4nios sexuais femininos e fen\u00f4menos tromboemb\u00f3licos: uma revis\u00e3o de literatura","volume":"5","author":"Borges TFC","year":"2015","journal-title":"Rev Ci\u00eanc Sa\u00fade"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0253-7613.111910","article-title":"Peripheral arterial disease in a female using high-dose combined oral contraceptive pills","volume":"45","author":"Pallavee P","year":"2013","journal-title":"Indian J Pharmacol"}],"container-title":["Revista Brasileira de Enfermagem"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/reben\/v71s3\/0034-7167-reben-71-s3-1453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T23:23:00Z","timestamp":1533165780000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-71672018000901453&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":29,"journal-issue":{"issue":"suppl 3","published-online":{"date-parts":[[2018]]}},"alternative-id":["S0034-71672018000901453"],"URL":"https:\/\/doi.org\/10.1590\/0034-7167-2017-0317","relation":{},"ISSN":["1984-0446","0034-7167"],"issn-type":[{"value":"1984-0446","type":"electronic"},{"value":"0034-7167","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}